By utilizing whole transcript oligonucleotide arrays, we identified DCC as a candidate gene for tumor progression in grade I and II meningiomas using an initial multiple group comparison that was performed on each meningioma against the BN samples which served as control set. This evidence concerns the gene DCC and meningioma.